Back
Sanara MedTech 10K Form
Sell
44
SMTI
Sanara MedTech
Last Price:
33.64
Seasonality Move:
51.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-05-12 | 10Q | SMTI/Sanara MedTech Quarterly |
2020-03-26 | 10K | SMTI/Sanara MedTech Annual |
2019-11-14 | 10Q | SMTI/Sanara MedTech Quarterly |
2019-08-14 | 10Q | SMTI/Sanara MedTech Quarterly |
2019-05-20 | 10Q | SMTI/Sanara MedTech Quarterly |
2019-04-01 | 10K | SMTI/Sanara MedTech Annual |
Receive SMTI News And Ratings
See the #1 stock for the next 7 days that we like better than SMTI
SMTI Financial Statistics
Sales & Book Value
Annual Sales: | $64.99M |
---|---|
Cash Flow: | $-1.47M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.77 |
Price / Book: | 7 |
Profitability
EPS (TTM): | -0.78000 |
---|---|
Net Income (TTM): | $-6.57M |
Gross Margin: | $57.14M |
Return on Equity: | -15.34% |
Return on Assets: | -9.33% |
Sanara MedTech Earnings Forecast
Key Sanara MedTech Financial Ratios
- The Gross Profit Margin over the past 23 years for SMTI is 87.92%.
- The Selling, General & Administrative Expenses for SMTI have been equal to 87.70% of Gross Profit Margin.
- The Research & Development expenses have been 6.36% of Revenue.
- The Interest Expense is -11.06% of Operating Income.
- The Net Earning history of SMTI is -6.62% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 11 years.
Sanara MedTech Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | SMTI |
Website: | sanaramedtech.com |
Debt
Debt-to-Equity Ratio: | 0.34 |
---|---|
Current Ratio: | 1.8 |
Quick Ratio: | 1.45 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SMTI Technical Analysis vs Fundamental Analysis
Sell
44
Sanara MedTech (SMTI)
is a Sell
Is Sanara MedTech a Buy or a Sell?
-
Sanara MedTech stock is rated a Sell
The current Sanara MedTech [SMTI] share price is $33.37. The Score for SMTI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.